Lifestyle and metabolic approaches to maximizing erectile and vascular health

Abstract

Oxidative stress and inflammation, which disrupt nitric oxide (NO) production directly or by causing resistance to insulin, are central determinants of vascular diseases including ED. Decreased vascular NO has been linked to abdominal obesity, smoking and high intakes of fat and sugar, which all cause oxidative stress. Men with ED have decreased vascular NO and circulating and cellular antioxidants. Oxidative stress and inflammatory markers are increased in men with ED, and all increase with age. Exercise increases vascular NO, and more frequent erections are correlated with decreased ED, both in part due to stimulation of endothelial NO production by shear stress. Exercise and weight loss increase insulin sensitivity and endothelial NO production. Potent antioxidants or high doses of weaker antioxidants increase vascular NO and improve vascular and erectile function. Antioxidants may be particularly important in men with ED who smoke, are obese or have diabetes. Omega-3 fatty acids reduce inflammatory markers, decrease cardiac death and increase endothelial NO production, and are therefore critical for men with ED who are under age 60 years, and/or have diabetes, hypertension or coronary artery disease, who are at increased risk of serious or even fatal cardiac events. Phosphodiesterase inhibitors have recently been shown to improve antioxidant status and NO production and allow more frequent and sustained penile exercise. Some angiotensin II receptor blockers decrease oxidative stress and improve vascular and erectile function and are therefore preferred choices for lowering blood pressure in men with ED. Lifestyle modifications, including physical and penile-specific exercise, weight loss, omega-3 and folic acid supplements, reduced intakes of fat and sugar, and improved antioxidant status through diet and/or supplements should be integrated into any comprehensive approach to maximizing erectile function, resulting in greater overall success and patient satisfaction, as well as improved vascular health and longevity.

Introduction

It is remarkable that a compound as unstable as nitric oxide (NO) evolved as the critical factor determining the capacity for an erection,1 and therefore perpetuation of our species. NO lasts only a few seconds in tissues due to its unbalanced electrons, and its production and stability depend on extensive antioxidant protection.

Antioxidant defenses are reduced in men with ED. In a study of levels of reduced glutathione (GSH), an important intracellular antioxidant, men with and without diabetes had significant decreases of GSH if they also had ED (1931±581 versus 2269±232 and 1671±438 versus 2084±118, mean±s.d. (μmol l−1), respectively, both P<0.001); diabetic men, as expected, had significantly lower levels than men without diabetes (Figure 1).2 In a study of young men with ED, serum levels of paraoxonase-1 activity were markedly lower (mean±s.d. 119±62 versus 185±56, P<0.001) compared with men without ED. Both low paraoxonase-1 activity and low high-density lipoprotein (HDL) cholesterol were independent predictors of ED in this population.3 Paraoxonase-1 is an HDL cholesterol-associated circulating antioxidant enzyme that appears to at least partially mediate many positive and negative atherogenic factors.4 These lower levels of both cellular and circulating antioxidants in men with ED are most likely due to oxidative stress and/or low antioxidant intake, rather than to inherent abnormalities of antioxidant protection. Oxidative stress5 and inflammatory factors such as C-reactive protein6 are increased in men with ED.

Figure 1
figure1

Red blood cell glutathione concentrations (μmol l−1) in 111 men with ED: 64 with diabetes mellitus (ED/DM); 47 without diabetes mellitus (ED/wDM); 20 diabetic subjects (DM) and 26 normal subjects (C). Adapted with permission.2

ED is associated with reduced NO production in the systemic vasculature. In normal weight men, mean±s.e. flow-mediated dilation (FMD) was 2.4±0.21% in the men with ED compared with 3.9±0.26% in the men without ED (P<0.001).7 This review will discuss various lifestyle and metabolic factors influencing vascular NO and erectile function, with an emphasis on the role of oxidative stress and inflammation, and specific interventions available to maximize erectile and vascular health.

Weight loss

Obesity is associated with increased pro-inflammatory cytokines such as tumor necrosis factor-α and interleukin-6.6 Obese individuals require more calories to maintain their weight and the burning of that extra fuel generates more reactive oxygen species.8 Men with ED with and without obesity have higher levels of C-reactive protein compared to men with normal erectile function.6, 7, 9 Tumor necrosis factor-α, interleukin-6, C-reactive protein and reactive oxygen species all cause insulin resistance. Insulin is an integral stimulator of vascular NO and thereby increased skeletal muscle glucose disposal. Insulin resistance therefore reduces vascular NO, causing increased circulating glucose, and hyperglycemia itself impairs insulin action and also increases the formation of advanced glycation end products, which increase reactive oxygen species and further impair NO production.10 Antioxidants increase NO and insulin sensitivity; for example, ingestion of cocoa has been shown to increase insulin sensitivity in various animal and human studies,11 and a potent polyphenolic antioxidant in green tea increases endothelial NO and insulin sensitivity in vitro and in vivo.12 In 110 obese men without diabetes, hypertension or dyslipidemia, ED was strongly correlated with waist/hip ratio and was significantly improved with weight loss and increased activity, which lowered glucose, insulin, waist/hip ratio, blood pressure and triglycerides, and increased endothelial NO production.13 In obese men, increased insulin sensitivity, induced by diet and vigorous activity and reflected by reduced circulating insulin, was very strongly correlated with increased NO production (r=0.83).14

Exercise

The most important lifestyle factor influencing ED is exercise,15 both systemic and penile (coital). Physical exercise causes increased systemic endothelial NO production through shear stress caused by the mechanical effect of increased blood flow,15, 16, 17 and with erection the increase of penile blood flow is many times greater than with physical exercise. In a study of men aged 55–75 years, more frequent coitus was associated with about a 50% reduction of ED, although establishing cause and effect would require a randomized study.18 ‘Penile rehabilitation’ is increasingly used to preserve erectile function following radical prostatectomy, using either a vacuum device19 or PDE-5 inhibitors.20 In a randomized, crossover study, pelvic floor exercises also reduced ED, most likely by reducing venous outflow from the penis.21

A sedentary lifestyle increases ED by 2–10-fold,22, 23, 24 whereas ‘moderate’ activity has been reported to reduce ED by two-thirds and ‘high’ activity by over 80% (unfortunately, these degrees of activity were not defined).25 Because penile blood flow presumably does not increase with physical exercise, the principal mechanism whereby physical exercise improves ED may be the pronounced effect of increased systemic NO on glucose disposal and insulin sensitivity (reviewed above). However, physical exercise also increases PON-1 activity,26 a circulating HDL-associated antioxidant enzyme reported to be lower in men with ED.3 The effect of exercise on NO is influenced by frequency as well as intensity. In an animal model, acute exercise increased NO release for 48 h, whereas daily exercise induced fourfold higher levels of NO production that lasted for a week.27 Moderate exercise may be preferable to extreme exercise. FMD is improved with moderate exercise, but extreme exercise increases oxidative stress and reduces FMD.15 Athletes also burn more calories and commonly load up with sugar and carbohydrates before participating in extreme exercise, which would further worsen those effects.

Reduced fat intake

A high fat meal increases oxidative stress and decreases FMD.28, 29 These effects were not observed in physically active compared to inactive adults.29 A high fat meal also increases inflammatory markers and soluble adhesion molecules.30 The increases of oxidative stress and inflammatory markers decrease vascular NO by interfering with insulin action,10 and also activate endothelial production of adhesion molecules, which may further contribute to atherosclerosis.30 Subjects with diabetes or the metabolic syndrome have exaggerated effects of a high fat meal on inflammation and endothelial activation.29, 30 Elevations of inflammatory markers and adhesion molecules were significantly decreased by high doses of vitamin C (1000 mg) and vitamin E (800 IU),30 suggesting that oxidative stress is involved in these adverse effects of postprandial hyperlipidemia. The safest dose of vitamin E will be discussed later in this manuscript.

Reduced blood sugar/sugar intake

Elevations of blood glucose raise interleukin-6, tumor necrosis factor-α and interleukin-18 in normal subjects and to a greater extent in individuals with impaired glucose tolerance.31 The increases were prevented by an infusion of GSH, showing that glucose stimulates circulating inflammatory markers through an oxidative mechanism. Ingesting antioxidants together with loading of fat and/or sugar may therefore help to reduce their adverse vascular effects. ED in diabetics is negatively correlated with better glycemic control and physical activity.32

Angiotensin receptor blockers

Short-acting angiotensin II receptor blockers have been reported to improve erectile function.16 In a randomized, double-blind, crossover study of men with type 2 diabetes and hypertension, an angiotensin II receptor blocker significantly decreased a marker of oxidative stress (P<0.001) and caused a significant increase of FMD compared with an angiotensin II-converting enzyme inhibitor (P=0.01).33

Testosterone

Circulating levels of testosterone correlate with NO production.34 Testosterone treatment can reduce central adiposity and insulin resistance,35 which may contribute to its beneficial effects on vascular NO and ED. Raising low testosterone levels improves ED35 and can restore erectile function in response to PDE-5 inhibitors.36

Smoking cessation

Both smoking and second-hand smoke increase the incidence of ED.37 Oxidative stress induced by smoking and cigarette smoke extract has been shown to uncouple endothelial NO synthase, which results in the production of superoxide and conversion of NO to peroxynitrite,38 a potent pro-oxidant that reduces endothelial NO synthase bioactivity.39 Antioxidants can recouple endothelial NO synthase39 and protect NO from destruction by these potent oxidants.40 The complete reversal of the effect of smoking on NO by high daily doses of vitamins C (1000 mg) and E (800 IU) (Figure 2) demonstrates that even these weak antioxidants can effectively counteract oxidative stress, provided the doses are sufficiently high.38 Besides efforts at quitting, early and aggressive supplementation with antioxidants may prevent ED and progressive vascular disease in these men.

Figure 2
figure2

Flow-mediated dilation (FMD) (mean±95% confidence limits) was significantly decreased in smokers. Administration of high-dose vitamins C and E for 165 days significantly improved FMD, whereas there was no significant change in non-smokers.38

Mild/moderate alcohol

Alcohol should be restricted to mild to moderate amounts (one to two drinks daily), which have been shown in a recent meta-analysis to reduce ED (odds ratio 0.79, 0.67–0.92, P<0.001).41 Moderate alcohol increases vascular NO in laboratory animals.42

Excessive alcohol

Excessive alcohol suppresses vascular NO and causes structural alterations in the penile endothelium of the mouse.42, 43 Excessive alcohol increases premature ejaculation, but studies clearly documenting increased ED are lacking.41, 44

Antioxidants

Polyphenols are potent antioxidants found in high amounts in certain foods. Pomegranate has been shown to increase endothelial NO and prevent its breakdown.40 Chocolate has been extensively examined for its favorable vascular effects.11 The effects of 22 g of cocoa with and without 45 g of sugar were examined on FMD. The cocoa, equivalent to a 40 g portion of chocolate with only 55% cocoa, had a markedly favorable effect on FMD (Figure 3).45 Sugar (45 g, an amount present in many 12 ounce sodas) abolished about two-thirds of that benefit. Dark chocolate with low sugar content (for example, 5–6 g per 40 g portion) is available with good flavor and would provide the maximum benefit on NO and vascular health. Tea increases NO46 and tea drinkers were shown to have a reduction of almost 50% of a second myocardial infarction.47 Red wine increases NO,48 but its antioxidant effects are confounded by the positive effects of alcohol (above). Fruits and vegetables contain varying amounts of antioxidants. Blueberries have been extensively touted for their antioxidant content, but strawberries and raspberries have similar amounts and cranberries have 50% more and blackberries almost 100% more compared to blueberries; some spices have up to 50-fold or more per weight than berries. Almost without exception, cooking increases the antioxidant content of foods.49 Pycnogenol is a commercial preparation of polyphenolic compounds that has been extensively investigated, is well standardized and improves erectile function at a dose of 80–120 mg per day.50 Ginseng has also been shown in a randomized trial to improve ED compared with placebo.50 Vitamin C increases vascular NO; a dose of 500 mg daily was shown to have a pronounced beneficial effect on blood pressure in patients with uncomplicated hypertension compared with placebo.51

Figure 3
figure3

In normal subjects, cocoa increased mean±s.e. flow-mediated dilation (FMD) compared with placebo, and sugar markedly suppressed its beneficial effect (both P<0.001).45 Adapted with permission.16

Folic acid and hyperhomocysteinemia

Folic acid stimulates NO and deficient intake is common; the recommended daily intake is 400 μg.52 Homocysteine levels are increased in men with ED, in some cases due to methylenetetrahydrofolate reductase gene polymorphisms,53 in which case higher than usual doses of folic acid may be necessary to normalize serum homocysteine levels.

Omega-3 fatty acids

Omega-3 fatty acids are associated with lower pro-inflammatory markers and increased anti-inflammatory markers,54 stabilize heart rhythm,55 lower serum triglycerides and directly increase NO production by endothelial cells. Addition of eicosapentaenoic acid to human endothelial cells caused an immediate, threefold increase of NO.56 All of these effects may contribute to the decrease of sudden cardiac death observed with omega-3 intake.57 Because the American Heart Association recommends 1000 mg of omega-3 fatty acids daily for individuals with established coronary artery disease, and these levels are ‘Generally Recognized As Safe’ by the United States Food and Drug Administration,57 500–1000 mg is a reasonable daily intake to maximize erectile and vascular health, particularly for men with ED under age 60 years or with diabetes or hypertension, who are at markedly increased risk for serious cardiac events.16

Renal failure

Approximately 70% of men with chronic kidney disease have ED, in part due to diabetes and depression.58 The lower incidence of ED in renal transplant patients compared to men having dialysis suggests that metabolic factors may play a role in the ED of men with chronic kidney disease.59 Decreased quality of life is strongly correlated with ED in men having dialysis,60 emphasizing that more attention should be paid to treating ED in these men.

Aging

Multiple population studies have documented the increase of ED with age, although the incidence with each advancing decade is much lower in the absence of coronary artery disease.61 Age-related increases of weight, insulin resistance, and oxidative stress and inflammation,8 and decreases of GSH synthesis,62 and coital frequency18 may be some of the mechanisms underlying the association of ED with age in men without coronary artery disease.

Other factors

Calcium supplementation causes a small but significant decrease of blood pressure, the effect being greater in individuals with insufficient dietary intake.63 Vitamin E is a weak antioxidant that increases the circulating levels of vitamin C.64 Vitamin E should be limited to 200 IU and should not be taken with aspirin.16 Substituting green tea for other beverages, together with 1000 mg of vitamin C and 200 mg of vitamin E daily, would be the least expensive choice for achieving good levels of antioxidants. L-Arginine has been disappointing as a supplement for ED or heart disease, probably because it is extensively metabolized in the gut wall and liver. Only a very large dose (5 g per day) has been reported to have some benefit on ED,65, 66 whereas smaller doses such as 1.5 g are ineffective (although commonly promoted).67

Response to PDE-5 inhibitors

NO causes penile muscle relaxation by increasing cyclic GMP.1 Consequently, all of the factors discussed above that increase NO would be expected to increase the response to PDE-5 inhibitors, which improve erectile function by inhibiting cyclic GMP breakdown and by enabling more frequent and sustained penile-specific exercise. PDE-5 inhibitors also can markedly improve antioxidant status. At peak blood levels following administration of 20 mg of tadalafil to men with ED, serum antioxidants rose 45%, serum oxidants declined 33% and serum paraoxonase-1 activity increased 50% (Figure 4, all P<0.0001).68 The magnitude of increase of PON-1 was great enough to reverse the reduction of PON-1 observed in men with ED (inset, Figure 4).3 This same dose given to men with cardiovascular risk factors caused a greater than twofold increase of FMD at the end of 4 weeks and continuing for 2 weeks after cessation of tadalafil (both P<0.01), whereas no changes were observed with placebo.16, 69 These marked increases of antioxidant status and vascular NO may be due to increased cyclic GMP reducing vascular superoxide levels and nicotinamide adenine dinucleotide phosphate oxidase expression;70 NO production requires both adequate antioxidant levels and nicotinamide adenine dinucleotide phosphate as a specific cofactor. This ancillary effect of PDE-5 inhibitors may contribute to blood pressure control. Systolic and diastolic blood pressures were lowered by 10 and 6 mm of mercury, respectively, in untreated hypertensive subjects given 50 mg of sildenafil three times daily for 16 days (P<0.01).71

Figure 4
figure4

In men with cardiovascular risk factors at 2 h after 20 mg of tadalafil, total serum antioxidant status (TAS) increased 45%, total serum oxidant status (TOS) decreased 33% and serum PON-1 activity increased 50% (all P<0.0001).68 Inset: PON-1 activity was significantly decreased in men with ED (P<0.001).3

Reduction of inflammation improves endothelial function and ED

More direct proof of a link between inflammation and ED is provided by experimentally producing and removing inflammation with concomitant assessment of endothelial and erectile function. When periodontal inflammation, which has been linked to cardiovascular disease, was aggressively treated, acute elevations of inflammatory markers were associated with a decrease of FMD. As the inflammation resolved over time, inflammatory markers regressed and FMD significantly increased.72 When periodontal inflammation was created in an animal model, inflammatory markers increased and intracavernosal pressure, NOS activity and cyclic GMP all significantly decreased.73 Minimizing infection and inflammation throughout the body, including avoiding fat accumulation, should improve both vascular and erectile health.

Future directions

Table 1 summarizes the lifestyle and metabolic factors having positive and negative effects on ED and/or vascular NO. In some cases, randomized controlled trials are not possible, such as with smoking, excessive alcohol or hyperhomocysteinemia, but others, such as the effect of omega-3 fatty acids on ED, are entirely possible and are conspicuously lacking. Further randomized trials are needed, including various combinations of the listed interventions,50 such as the favorable effects on ED of combining testosterone and sildenafil,36 or of the Mediterranean diet, which increases intakes of omega-3's, antioxidants and folic acid.74

Table 1 Summary of lifestyle and metabolic factors having positive (+) or negative (−) effects on ED or vascular NO demonstrated by *randomized trials or **observational studies

Lifestyle and nutritional counseling

Lifestyle modification should be included in any clinical management of ED. To aid practitioners in providing this information, three of the authors (DRM, JCG and MAM) have established a website, http: //www.erectile-function.com,75 which provides information regarding erectile function and a healthy lifestyle, and a PowerPoint presentation and a more extensive reference list for healthcare professionals free of charge.

Summary

Oxidative stress, decreased antioxidant defenses and inflammation are prevalent in men with ED and play major roles in reducing vascular NO. Poor lifestyle choices increase oxidative stress, inflammation and ED, and reduced oxidative stress and inflammation occur with multiple interventions that increase NO and improve erectile function. Understanding the influence of lifestyle and metabolic factors on erectile health will help practitioners to integrate a more comprehensive approach into their treatments of impotence, resulting in greater overall success and a higher level of satisfaction and vascular health for their patients.

References

  1. 1

    Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ . Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90–94.

  2. 2

    Tagliabue M, Pinach S, Di Bisceglie C, Brocato L, Cassader M, Bertagna A et al. Glutathione levels in patients with erectile dysfunction, with or without diabetes mellitus. Int J Androl 2005; 28: 156–162.

  3. 3

    Ciftci H, Yeni E, Savas M, Verit A, Celik H . Paraoxinase activity in patients with erectile dysfunction. Int J Impot Res 2007; 19: 517–520.

  4. 4

    Soran H, Jounis NN, Charlton-Menys V, Durrington P . Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 2009; 20: 265–274.

  5. 5

    Aldemir M, Okulu E, Neselioglu S, Erel O, Ener K, Kayigil O . Evaluation of serum oxidative and antioxidative status in patients with erectile dysfunction. Andrologia 2011; e-pub ahead of print 30 June; doi: 10.1111/j.1439-0272.2011.01174.x.

  6. 6

    Giugliano F, Esposito K, Di Palo C, Ciotola M, Giugliano G, Marfella R et al. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokines in obese men. J Endocrinol Invest 2004; 27: 665–669.

  7. 7

    Chiurlia E, D'Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG . Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005; 46: 1503–1506.

  8. 8

    Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R . Mechanisms underlying caloric restriction and life span regulation: implications for vascular aging. Circ Res 2008; 102: 519–528.

  9. 9

    Esposito K, Giugliano F, Martedi E, Feola G, Marfella R, D'Armiento M et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005; 28: 1201–1203.

  10. 10

    Muniyappa R, Quon MJ . Insulin action and insulin resistance in vascular endothelium. Curr Opin Clin Nutr Metab Care 2007; 10: 523–530.

  11. 11

    Katz D, Doughty K, Ali A . Cocoa and chocolate in human health and disease. Antioxid Redox Signal 2011; 15: 2779–2811.

  12. 12

    Potenza MA, MarasciuloFL, Tarquinio M, Tiravanti E, Colantuono G, Federici A et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 2007; 292: E1378–E1387.

  13. 13

    Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled study. JAMA 2004; 291: 2978–2984.

  14. 14

    Roberts CK, Nosratola D, Vaziri MD, Barnard J . Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002; 106: 2530–2532.

  15. 15

    Ignarro LJ, Balestrieri ML, Napoli C . Nutrition, physical activity and cardiovascular disease: an update. Cardiovasc Res 2007; 73: 326–340.

  16. 16

    Meldrum DR, Gambone JC, Morris MA, Meldrum DAN, Esposito K, Ignarro LJ . The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol 2011; 108: 599–606.

  17. 17

    Buga GM, Gold ME, Fukuto JM, Ignarro LJ . Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991; 17: 187–193.

  18. 18

    Koskimaki J, Shiri R, Tammela T, Hakkinen J, Hakama M, Auvinen A . Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med 2008; 121: 592–596.

  19. 19

    Yuan J, Hoang AN, Romero CA, Lin H, Dai Y, Wang R . Vacuum therapy in erectile dysfunction—science and clinical evidence. Int J Impot Res 2010; 22: 211–219.

  20. 20

    Pace G, Del Rosso A, Vicentini C . Penile rehabilitation therapy following radical prostatectomy. Disabil Rehab 2010; 32: 1204–1208.

  21. 21

    Dorey G, Speakman MJ, Feneley RCL, Swinkels A, Dunn CDR . Pelvic floor exercises for erectile dysfunction. BJU Int 2005; 96: 595–597.

  22. 22

    Selvin E, Burnett AL, Platz EA . Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007; 120: 151–157.

  23. 23

    Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB . Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003; 139: 161–168.

  24. 24

    Agostini LCM, Netto JMB, Miranda MV, Figueiredo AA . Erectile dysfunction association with physical activity level and physical fitness in men aged 40–75 years. Int J Impot Res 2011; 23: 115–121.

  25. 25

    Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, et al. (Turkish Erectile Dysfunction Prevalence Study Group). Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002; 41: 298–304.

  26. 26

    Senti M, Tomas M, Anglada R, Elosua R, Marrugat J, Covas MI et al. Interrelationship of smoking, paraoxinase activity, and leisure time physical activity: a population-based study. Eur J Intern Med 2003; 14: 178–184.

  27. 27

    Haram PM, Adams V, Kemi OJ, Brubakk AO, Hambrecht R, Ellingsen O et al. Time-course of endothelial adaptation following acute and regular exercise. Eur J Cardiovasc Prev Rehab 2006; 13: 585–591.

  28. 28

    Esposito K, Ciotola M, Sasso FC, Cozzolino D, Saccomanno F, Assaloni R et al. Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: role of tumor necrosis factor-alpha. Nutr Metab Cardiovasc Dis 2007; 17: 274–279.

  29. 29

    Johnson BD, Padilla J, Harris RA, Wallace JP . Vascular consequences of a high-fat meal in physically active and inactive adults. Appl Physiol Nutr Metab 2011; 36: 368–375.

  30. 30

    Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002; 39: 1145–1150.

  31. 31

    Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067–2072.

  32. 32

    Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K . Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res 2010; 22: 204–209.

  33. 33

    Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hurlimann D et al. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J Hypertens 2007; 25: 785–791.

  34. 34

    Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M et al. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res 2007; 30: 1029–1034.

  35. 35

    Stanworth RD, Jones TH . Testosterone for the aging male: current evidence and recommended practice. Clin Interv Aging 2008; 3: 25–44.

  36. 36

    Rosenthal BD, May NR, Metro MJ, Harkaway RC, Gindberg PC . Adjunctive use of androgel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology 2006; 67: 571–574.

  37. 37

    Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328–338.

  38. 38

    Peluffo G, Calcerrada P, Piacenza L, Pizzano N, Radi F . Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers. Am J Physiol Heart Circ Physiol 2009; 296: H1781–H1792.

  39. 39

    Napoli C, Ignarro LJ . Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 2009; 32: 1103–1108.

  40. 40

    Ignarro LJ, Byrns RE, Sumi D, de Nigris F, Napoli C . Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biologic actions of nitric oxide. Nitric Oxide 2006; 15: 93–102.

  41. 41

    Cheng JYW, Ng EML, Chen RL, Ko JSN . Alcohol consumption and erectile dysfunction: meta-analysis of population-based studies. Int J Impot Res 2007; 19: 343–352.

  42. 42

    Abou-agag LH, Khoo NK, Binsack R, White CR, Darley-Usmar V, Grenett HE et al. Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide. Free Radic Biol Med 2005; 39: 540–548.

  43. 43

    Aydinoglu F, Yilmaz SN, Coskun B, Daglioglu N, Ogulener N . Effects of ethanol treatment on the neurogenic and endothelium-dependent relaxation of corpus cavernosum smooth muscle in the mouse. Pharmacol Rep 2008; 60: 725–734.

  44. 44

    Christensen BS, Gronbaek M, Pedersen BV, Graugaard C, Frisch M . Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark. J Sex Med 2011; 8: 1903–1916.

  45. 45

    Faridi Z, Njike VY, Dutta S, Ali A, Katz DL . Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr 2008; 88: 58–63.

  46. 46

    Persson IA, Josefsson M, Persson K, Andersson RG . Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 2006; 58: 1139–1144.

  47. 47

    Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA . Tea consumption and mortality after acute myocardial infarction. Circulation 2002; 105: 2476–2481.

  48. 48

    Wallerath T, Poleo D, Li H, Forstermann U . Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 2003; 41: 471–478.

  49. 49

    Halvorsen BL, Carlsen MH, Phillips KM, Bohn SK, Holte K, Jacobs DR et al. Content of redox-active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr 2006; 84: 95–135.

  50. 50

    Meldrum DR, Gambone JC, Morris MA, Ignarro LJ . A multifaceted approach to maximize erectile function and vascular health. Fertil Steril 2010; 94: 2514–2520.

  51. 51

    Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048–2049.

  52. 52

    Moens AL, Vrints CJ, Claeys MJ, Timmermans JP, Kass DA . Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 2008; 249: H1971–H1977.

  53. 53

    Safarinejad MR, Safarinejad S, Shafiei N . Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset vasculogenic erectile dysfunction. Arch Med Res 2010; 41: 410–422.

  54. 54

    Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439–446.

  55. 55

    Xiao YF, Sigg DC, Leaf A . The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ionic channels as a potential mechanism. J Membr Biol 2005; 206: 141–154.

  56. 56

    Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997; 232: 487–491.

  57. 57

    Kris-Etherton PM, Harris WS, Appel LJ . American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747–2757.

  58. 58

    Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis 2010; 56: 670–685.

  59. 59

    Travallai SA, Mirzamani M, Heshmatzade BA, Assari S, Khoddami Vishteh HR, Hajarizadeh B et al. Sexual function: a comparison between male renal transplant recipients and hemodialysis patients. J Sex Med 2009; 6: 142–148.

  60. 60

    Fernandes GV, dos Santos RR, Soares W, de Lima LG, de Macedo BS, da Fonte JE et al. The impact of erectile dysfunction on the quality of life of men undergoing hemodialysis and its association with depression. J Sex Med 2010; 7: 4003–4010.

  61. 61

    Inman BA, St Sauver JL, Jacobson DL, Mcgree ME, Nehra A, Lieber MM et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108–113.

  62. 62

    Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 2004; 101: 3381–3386.

  63. 63

    van Mierlo LAJ, Arends LR, Streppel MT, Zeegers MPA, Kok FJ, Grobbee DE et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006; 20: 571–580.

  64. 64

    Hamilton IM, Gilmore WS, Benzie IF, Mulholland CW, Strain JJ . Interactions between vitamins C and E in human subjects. Br J Nutr 2000; 84: 261–267.

  65. 65

    Zorgniotti AW, Lizza EF . Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction. Int J Impot Res 1994; 6: 33–35.

  66. 66

    Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H . Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int 1999; 83: 269–273.

  67. 67

    Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U . Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int 1999; 63: 220–223.

  68. 68

    Verit A, Savas M, Ciftci H, Aksoy N, Taskin A, Topal U . Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study. Int J Impot Res 2010; 22: 115–119.

  69. 69

    Rosano GMC, Aversa A, Vitale C, Fabbri A, Fini M, Spera G . Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005; 47: 214–222.

  70. 70

    Schafer A, Fraccarollo D, Pfortsch S, Flierl U, Vogt C, Pfrang J et al. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol 2008; 153: 886–893.

  71. 71

    Oliver JJ, Melville VP, Webb DJ . Effect of regular phosphodiesterase type 5 inhibition in hypertension. Hypertension 2006; 48: 622–627.

  72. 72

    Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911–920.

  73. 73

    Zuo Z, Jiang J, Jiang R, Chen F, Liu J, Yang H et al. Effect of periodontitis on erectile function and its possible mechanism. J Sex Med 2011; 8: 2598–2605.

  74. 74

    Esposito K, Ciotola M, Giugliano F, De Sio M, Giugliano G, D'armiento M et al. Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 2006; 18: 405–410.

  75. 75

    Meldrum DR, Gambone JC, Morris MA . Erectile-function. Available at: http://erectile-function.com. (accessed 11 September 2011).

Download references

Author information

Correspondence to D R Meldrum.

Ethics declarations

Competing interests

DRM, JCG and MAM are shareholders of Sexuality EDucation Network, which operates the website http: //www.erectile-function.com.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Meldrum, D., Gambone, J., Morris, M. et al. Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res 24, 61–68 (2012). https://doi.org/10.1038/ijir.2011.51

Download citation

Keywords

  • ED
  • inflammatory markers
  • lifestyle
  • nitric oxide
  • oxidative stress
  • PDE-5 inhibitors

Further reading